Pharma Integrates
Industry’s shift towards large molecules and how to maintain balance
Executives from the largest companies in the industry discuss the increasing prevalence of biologics and the future focus for therapeutics at Pharma Integrates.
Archives for November 21, 2019
Teva spinout eyes outsourced manufacturing scale up after $85M IPO
89bio plans to invest up to $10m (€9m) in manufacturing and scale up, after raising $85m in an upsized IPO.
Fujifilm expands gene therapy analytical services with $55m lab
Fujifilm Diosynth opens a 60,000-square-feet Gene Therapy Innovation Center to support upstream, downstream and analytical development services.
Pfizer joins the Humira queue after biosimilar approval
Pfizer becomes the latest company to have a biosimilar approved by the US FDA, only to have to wait until 2023 to launch.
Microbiome therapies approaching ‘key inflection point’
After Finch Therapeutics extends partnership with Takeda, the biotech’s CEO outlines how next year could be a defining one for microbiome-based therapies.